GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Market Cap

Biogena Group Invest AG (WBO:BIO) Market Cap : €8.62 Mil (As of May. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Biogena Group Invest AG's share price for the quarter that ended in Jan. 2024 was €1.86. Biogena Group Invest AG's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 3.99 Mil. Therefore, Biogena Group Invest AG's market cap for the quarter that ended in Jan. 2024 was €7.42 Mil.

Biogena Group Invest AG's quarterly market cap increased from Jan. 2022 (€11.49 Mil) to Jan. 2023 (€11.73 Mil) but then declined from Jan. 2023 (€11.73 Mil) to Jan. 2024 (€7.42 Mil).

Biogena Group Invest AG's annual market cap increased from Jan. 2022 (€11.49 Mil) to Jan. 2023 (€11.73 Mil) but then declined from Jan. 2023 (€11.73 Mil) to Jan. 2024 (€7.42 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Biogena Group Invest AG's Enterprise Value for Today is €8.60 Mil.


Biogena Group Invest AG Market Cap Historical Data

The historical data trend for Biogena Group Invest AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Market Cap Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Market Cap
8.60 11.49 11.73 7.42

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Market Cap 8.60 11.49 11.73 7.42

Competitive Comparison of Biogena Group Invest AG's Market Cap

For the Packaged Foods subindustry, Biogena Group Invest AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Market Cap Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Market Cap falls into.



Biogena Group Invest AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Biogena Group Invest AG's Market Cap for the fiscal year that ended in Jan. 2024 is calculated as

Market Cap (A: Jan. 2024 )=Share Price (A: Jan. 2024 )*Shares Outstanding (EOP) (A: Jan. 2024 )
=€1.86*3.99
=€7.42

Biogena Group Invest AG's Market Cap for the quarter that ended in Jan. 2024 is calculated as

Market Cap (Q: Jan. 2024 )=Share Price (Q: Jan. 2024 )*Shares Outstanding (EOP) (Q: Jan. 2024 )
=€1.86*3.99
=€7.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Biogena Group Invest AG Market Cap Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.